-
1 Comment
Jiangsu Lianhuan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 6.7% below its 200 day moving average.
From a valuation standpoint, the stock is 82.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Jiangsu Lianhuan Pharmaceutical Co., Ltd's total revenue rose by 4.9% to $421M since the same quarter in the previous year.
Its net income has increased by 31.3% to $24M since the same quarter in the previous year.
Finally, its free cash flow grew by 11.6% to $-21M since the same quarter in the previous year.
Based on the above factors, Jiangsu Lianhuan Pharmaceutical Co., Ltd gets an overall score of 4/5.
| CurrencyCode | CNY |
|---|---|
| ISIN | CNE000001DP6 |
| Exchange | SHG |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.51 |
|---|---|
| Target Price | None |
| Dividend Yield | 0.4% |
| Market Cap | 6B |
| PE Ratio | None |
Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprilite, danazol suppositories, and terfenadine tablets. It also provides urinary system drugs, including eprepitant tablets, terazosin tablets, and drotaverine hydrochloride injections; antihistamines comprising ebastine, terfenadine, and cetirizine hydrochloride tablets; cardiovascular drugs that include felodipine, simvastatin, and amlodipine maleate tablets; steroid hormones, which consist of prazosinone sulfate sodium for injection and danazol capsules; and antibiotics, such as oxithromycin capsules. In addition, the company offers API products, such as hydrocortisone, hydrocortisone acetate, levonorgestrel, dexamethasone sodium phosphate, dexamethasone acetate, tazarotene, saxagliptin monohydrate, sacubitril valsartan sodium, phentolamine mesylate, terfenadine, aminomethylbenzoic acid, drotaverine hydrochloride, felodipine, ebastine, lumbrokinase, chloramphenicol, balofoxacin, fludrocortisone acetate, relugolix, hydrocortisone valerate, and bilastine. Further, it engages in the wholesale of chemical raw materials and pharmaceuticals, as well as the sale of medical equipment and electronic products. The company exports its products. Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 1999 and is based in Yangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600513.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
